Recalling a Radical Shift in the Management of Patients With Type 2 Diabetes and Obesity

Sean Wharton, MD, PharmD, recalls treating patients with type 2 diabetes with high doses of insulin in his early days of medical school, which often led to patient weight gain. Dr Wharton notes how this practice encapsulated the contradictory nature of lowering a patient's blood sugars while increasing their likelihood for comorbidities associated with weight gain.

Now, almost 25 years later, Dr Wharton sees a radical difference in how patients with type 2 diabetes are managed with medications that can manage both weight gain and lower blood sugar levels, thereby mitigating risk factors for weight-related comorbidities.

Medscape © 2023 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Recalling a Radical Shift in the Management of Patients With Type 2 Diabetes and Obesity - Medscape - Feb 28, 2023.